TVAX BIOMEDICAL
TVAX Biomedical is a clinical stage development company advancing its targeted cell-based immunotherapy for the treatment of cancer. The company’s proprietary therapeutic approach offers the promise of improved clinical outcomes, low toxicity and the potential for fundamentally changing the way cancer is treated. TVAX Immunotherapy is a unique personalized combination of cancer cell vaccination and “killer” T cell treatment. This treatment has demonstrated the potential to effectivel... y treat numerous cancers without many of the undesirable side effects associated with radiation and chemotherapy. A key distinction between TVAX and other cancer immunotherapy companies is that TVI uses its patented approach to combine both cancer vaccination and activated “killer” T cell treatment. While each of these separate approaches has demonstrated therapeutic potential, neither has demonstrated the efficacy to be a viable standalone treatment.
TVAX BIOMEDICAL
Social Links:
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2004-01-01
Address:
Lenexa, Kansas, United States
Country:
United States
Website Url:
http://www.tvaxbiomedical.com
Total Employee:
1+
Status:
Active
Contact:
(913) 492-2221
Email Addresses:
[email protected]
Total Funding:
14.68 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Analytics Microsoft Exchange Online Google Office 365 Mail Microsoft Azure DNS JQuery CDN
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
DEKK-TEC, Inc.
Novel therapies for the treatment of cancer.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.tvaxbiomedical.com Semrush global rank: 5.79 M Semrush visits lastest month: 1.23 K
- Host name: 26.141.209.35.bc.googleusercontent.com
- IP address: 35.209.141.26
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "TVAX Biomedical"
TVAX Biomedical - Crunchbase Company Profile
TVAX Biomedical is a clinical stage development company advancing its targeted cell-based immunotherapy for the treatment of cancer. The company’s proprietary therapeutic approach offers the promise of improved clinical outcomes, low …See details»
TVAX Biomedical, Inc. | LinkedIn
TVAX Biomedical, Inc. | 389 followers on LinkedIn. Vaccine-enhanced adoptive T cell immunotherapy ...developing an immune response against one's own tumor. | TVAX Biomedical is a biotechnology ...See details»
Tvax Biomedical I, LLC - Dun & Bradstreet
Company Description: TVAX may be a clever play on the company's methods but it is completely serious about killing cancer. TVAX Biomedical uses cancer cell vaccination and the …See details»
TVAX Biomedical Inc - Company Profile and News
Company profile page for TVAX Biomedical Inc including stock price, company news, executives, board members, and contact informationSee details»
TVAX Biomedical, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TVAX Biomedical, Inc. of Lenexa, KS. Get the latest business insights from Dun & Bradstreet.See details»
TVAX Biomedical - PitchBook
TVAX Biomedical General Information Description. Developer of targeted cell-based immunotherapies designed to provide paradigm-shifting cancer treatment. The company's …See details»
TVAX Biomedical Company Profile - Office Locations, Competitors …
TVAX Biomedical has 5 employees across 2 locations and $13.3 m in total funding,. See insights on TVAX Biomedical including office locations, competitors, revenue, financials, executives, …See details»
TVAX Biomedical announces major advancements in potential …
OLATHE, Kan., Dec. 9, 2020 /PRNewswire/ -- TVAX Biomedical (TVAX), is a cancer immunotherapy company that is moving into its pivotal glioblastoma study for FDA regulatory …See details»
TVAX Biomedical Asset Profile - Preqin
TVAX Biomedical, is based in Lenexa, US and is a clinical stage drug development company advancing its novel targeted cell-based immunotherapy for the treatment of cancer.See details»
Tvax Biomedical Inc. - BioCentury Company Profiles - BCIQ
Jan 14, 2013 Tvax Biomedical Inc. - BioCentury Company Profiles for the biopharma industrySee details»
TVAX Biomedical Receives Fast Track Designation from the FDA …
OLATHE, Kan., June 4, 2020 /PRNewswire/ -- TVAX Biomedical announced today receipt of Fast Track Designation from the U.S. Food and Drug Administration (FDA) for the use of its vaccine …See details»
TVAX Biomedical Announces Receipt of $2 Million FDA Orphan …
Oct 18, 2022 Patient with recurrent high-grade glioma treated with TVAX Immunotherapy Patient with recurrent high-grade glioma treated with TVAX Immunotherapy OLATHE, Kan., Oct. 18, …See details»
Capital Health Partnering with TVAX Biomedical to Offer Brain …
Jul 2, 2024 Only Participating Clinical Site in the Northeast United States. Capital Health Cancer Center has announced that it has joined TVAX Biomedical, Inc.’s clinical trial to study a …See details»
TVAX Biomedical Announces Receipt of $2 Million FDA Orphan …
OLATHE, Kan., Oct. 18, 2022 (GLOBE NEWSWIRE) -- TVAX Biomedical (TVAX) is a cancer immunotherapy company that is moving into its pivotal glioblastoma study for FDA regulatory …See details»
Capital Health Partnering with TVAX Biomedical to Offer Brain …
Jul 8, 2024 Only Participating Clinical Site in the Northeast United States. HOPEWELL, N.J., July 8, 2024 /PRNewswire/ -- Capital Health Cancer Center has announced that it has joined …See details»
TVAX Biomedical Announces Receipt of $2 Million FDA Orphan
OLATHE, Kan., Oct. 18, 2022 (GLOBE NEWSWIRE) -- TVAX Biomedical (TVAX) is a cancer immunotherapy company that is moving into its pivotal glioblastoma study for FDA regulatory …See details»
Why Canada excels at medical tech startups - The Globe and Mail
1 day ago The incubator program at the University of Toronto’s Mississauga campus – which opened its doors to its first 15 startups in the first cohort in May – is one of the few in Canada …See details»
TVAX Biomedical Receives Fast Track Designation for Brain Cancer ...
Jun 12, 2020 TVAX Biomedical announced receipt of Fast Track Designation from the U.S. Food and Drug Administration (FDA) for the use of its vaccine-enhanced adoptive T cell therapy …See details»
FDA grants fast track designation to vaccine-enhanced cell
Jun 9, 2020 The FDA granted fast track designation to TVI-Brain-1, an adoptive T cell therapy for the treatment of glioblastoma multiforme, according to the agent’s manufacturer. TVI-Brain …See details»
TVAX Biomedical - Company Profile - Tracxn
Nov 5, 2024 TVAX Biomedical - Targeted T cell-based immunotherapies for brain cancer & renal cell carcinoma.. Raised a total funding of $9.52M over 5 rounds from 2 investors. Founded by …See details»